Short-Read Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

Short-Read Sequencing Market Report: Trends, Forecast and Competitive Analysis to 2030

Short-Read Sequencing Trends and Forecast

The future of the global short-read sequencing market looks promising with opportunities in the academic & research institute, hospital & clinic, and pharmaceutical & biotechnology markets. The global short-read sequencing market is expected to reach an estimated $17.1 billion by 2030 with a CAGR of 18.9% from 2024 to 2030. The major drivers for this market are growing demand from research and clinical centers and increasing preference for personalized medicine.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Short-Read Sequencing by Segment

The study includes a forecast for the global short-read sequencing by product type, workflow, application, end use, and region.

Short-Read Sequencing Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Consumables
• Services

Short-Read Sequencing Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

• Pre-Sequencing
• Sequencing
• Data Analysis

Short-Read Sequencing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing
• Others

Short-Read Sequencing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Academic & Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology
• Others

Short-Read Sequencing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Short-Read Sequencing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies short-read sequencing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the short-read sequencing companies profiled in this report include-

• Illumina
• Thermo Fisher Scientific
• Pacific Biosciences of California
• BGI
• QIAGEN
• Agilent Technologies
• Psomagen
• Azenta
• PerkinElmer
• ProPhase Labs

Short-Read Sequencing Market Insights

Lucintel forecasts that targeted will remain the largest segment as it is simpler, less time-consuming, makes analysis more precise, and increases accuracy.

Within this market, academic and research institute will remain the largest segment.

North America wil remain the largest region due to existence of robust healthcare infrastructure, rising favourable government funding for research and development, and presence of key players in the region.

Features of the Global Short-Read Sequencing Market

Market Size Estimates: Short-read sequencing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Short-read sequencing market size by various segments, such as by product type, workflow, application, end use, and region in terms of ($B).

Regional Analysis: Short-read sequencing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, workflows, applications, end uses, and regions for the short-read sequencing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the short-read sequencing market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q.1 What is the short-read sequencing market size?

Answer: The global short-read sequencing market is expected to reach an estimated $17.1 billion by 2030.

Q.2 What is the growth forecast for short-read sequencing market?

Answer: The global short-read sequencing market is expected to grow with a CAGR of 18.9% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the short-read sequencing market?

Answer: The major drivers for this market are growing demand from research and clinical centers and increasing preference for personalized medicine.

Q4. What are the major segments for short-read sequencing market?

Answer: The future of the short-read sequencing market looks promising with opportunities in the academic & research institute, hospital & clinic, and pharmaceutical & biotechnology markets.

Q5. Who are the key short-read sequencing market companies?

Answer: Some of the key short-read sequencing companies are as follows:

• Illumina
• Thermo Fisher Scientific
• Pacific Biosciences of California
• BGI
• QIAGEN
• Agilent Technologies
• Psomagen
• Azenta
• PerkinElmer
• ProPhase Labs

Q6. Which short-read sequencing market segment will be the largest in future?

Answer: Lucintel forecasts that targeted will remain the largest segment as it is simpler, less time-consuming, makes analysis more precise, and increases accuracy.

Q7. In short-read sequencing market, which region is expected to be the largest in next 5 years?

Answer: North America wil remain the largest region due to existence of robust healthcare infrastructure, rising favourable government funding for research and development, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the short-read sequencing market by product type (instruments, consumables, and services), workflow (pre-sequencing, sequencing, and data analysis), application (whole genome sequencing, whole exome sequencing, targeted sequencing & resequencing, and others), end use (academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.